News

March 24, 2024

Thermal ablation with NK-cell based immunotherapy may improve HCC outcomes

While thermal ablation currently provides excellent outcomes for early-stage hepatocellular carcinoma (HCC), a new study indicates that applying nonlethal hyperthermia may also improve natural killer (NK) cell cytotoxicity and effect better outcomes for multiple HCC cell lines.

Read More:  http://irq.sirweb.org/sirtoday/thermal-ablation-nk-cell-immunotherapy-HCC-abstract-164/